Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
genetic testing
Genomics Researchers Have a Bone to Pick with Multiple Myeloma
Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.